vsv g envelope expressing vector pmd2 g (Addgene inc)
Addgene inc is a verified supplier 
98
Structured Review
Addgene inc
vsv g envelope expressing vector pmd2 g
Vsv G Envelope Expressing Vector Pmd2 G, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 14780 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pmd2+g+vsv+g+envelope+vector+pmd2+g/pMD2%2EG+(Plasmid+%2312259)/pm40412468-194-13-20
Average 98 stars, based on 14780 article reviews
Vsv G Envelope Expressing Vector Pmd2 G, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 14780 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pmd2+g+vsv+g+envelope+vector+pmd2+g/pMD2%2EG+(Plasmid+%2312259)/pm40412468-194-13-20
Average 98 stars, based on 14780 article reviews
vsv g envelope expressing vector pmd2 g - by Bioz Stars,
2026-10
98/100 stars
Images
Related Articles
Recombinant:Article Title: Rewriting regulatory DNA to dissect and reprogram gene expression. Article Snippet: Generating doxycycline-inducible prime editing (PE2) cell lines We generated inducible PE2 (nCas9-MMLV) prime editing cell lines by first transducing THP-1 and Jurkat cells with a EF1ɑ-rtTAIRES-Neo plasmid (Clontech, Mountain View, CA), which expresses a reverse tetracycline transactivator (rtTA) and a neomycin resistance gene from the EF1ɑ promoter. Plasmid Preparation:Article Title: Rewriting regulatory DNA to dissect and reprogram gene expression. Article Snippet: Generating doxycycline-inducible prime editing (PE2) cell lines We generated inducible PE2 (nCas9-MMLV) prime editing cell lines by first transducing THP-1 and Jurkat cells with a EF1ɑ-rtTAIRES-Neo plasmid (Clontech, Mountain View, CA), which expresses a reverse tetracycline transactivator (rtTA) and a neomycin resistance gene from the EF1ɑ promoter. Software:Article Title: Rewriting regulatory DNA to dissect and reprogram gene expression. Article Snippet: Generating doxycycline-inducible prime editing (PE2) cell lines We generated inducible PE2 (nCas9-MMLV) prime editing cell lines by first transducing THP-1 and Jurkat cells with a EF1ɑ-rtTAIRES-Neo plasmid (Clontech, Mountain View, CA), which expresses a reverse tetracycline transactivator (rtTA) and a neomycin resistance gene from the EF1ɑ promoter. Variant Assay:Article Title: Rewriting regulatory DNA to dissect and reprogram gene expression. Article Snippet: Generating doxycycline-inducible prime editing (PE2) cell lines We generated inducible PE2 (nCas9-MMLV) prime editing cell lines by first transducing THP-1 and Jurkat cells with a EF1ɑ-rtTAIRES-Neo plasmid (Clontech, Mountain View, CA), which expresses a reverse tetracycline transactivator (rtTA) and a neomycin resistance gene from the EF1ɑ promoter. RNA Sequencing:Article Title: Rewriting regulatory DNA to dissect and reprogram gene expression. Article Snippet: Generating doxycycline-inducible prime editing (PE2) cell lines We generated inducible PE2 (nCas9-MMLV) prime editing cell lines by first transducing THP-1 and Jurkat cells with a EF1ɑ-rtTAIRES-Neo plasmid (Clontech, Mountain View, CA), which expresses a reverse tetracycline transactivator (rtTA) and a neomycin resistance gene from the EF1ɑ promoter. Chromatin Immunoprecipitation:Article Title: Rewriting regulatory DNA to dissect and reprogram gene expression. Article Snippet: Generating doxycycline-inducible prime editing (PE2) cell lines We generated inducible PE2 (nCas9-MMLV) prime editing cell lines by first transducing THP-1 and Jurkat cells with a EF1ɑ-rtTAIRES-Neo plasmid (Clontech, Mountain View, CA), which expresses a reverse tetracycline transactivator (rtTA) and a neomycin resistance gene from the EF1ɑ promoter. Gene Expression:Article Title: Rewriting regulatory DNA to dissect and reprogram gene expression. Article Snippet: Generating doxycycline-inducible prime editing (PE2) cell lines We generated inducible PE2 (nCas9-MMLV) prime editing cell lines by first transducing THP-1 and Jurkat cells with a EF1ɑ-rtTAIRES-Neo plasmid (Clontech, Mountain View, CA), which expresses a reverse tetracycline transactivator (rtTA) and a neomycin resistance gene from the EF1ɑ promoter. |